The urokinase‐type plasminogen activator system as drug target in retinitis pigmentosa: New pre‐clinical evidence in the rd10 mouse model-Reference-Cited by-同舟云学术

The urokinase‐type plasminogen activator system as drug target in retinitis pigmentosa: New pre‐clinical evidence in the rd10 mouse model

Published:2019-06-28 Issue:8 Volume:23 Page:5176-5192
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Cammalleri Maurizio¹,Dal Monte Massimo¹^ORCID,Locri Filippo¹,Pecci Valeria¹,De Rosa Mario²,Pavone Vincenzo³,Bagnoli Paola¹

Affiliation:

1. Department of Biology University of Pisa Pisa Italy

2. Department of Experimental Medicine Second University of Napoli Napoli Italy

3. Department of Chemical Sciences University of Napoli Federico II Napoli Italy

Funder

Italian Ministry of Health

Kaleyde Pharmaceuticals AG

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.14391

Reference56 articles.

1. Neuroinflammation in Retinitis Pigmentosa, Diabetic Retinopathy, and Age-Related Macular Degeneration: A Minireview

2. Clinical Evidence of Sustained Chronic Inflammatory Reaction in Retinitis Pigmentosa

3. INTRAVITREAL DEXAMETHASONE IMPLANT IN RETINITIS PIGMENTOSA–RELATED CYSTOID MACULAR EDEMA

4. Melatonin delays photoreceptor degeneration in a mouse model of autosomal recessive retinitis pigmentosa

5. The urokinase plasminogen activation system in rheumatoid arthritis: pathophysiological roles and prospective therapeutic targets;Buckley BJ;Curr Drug Targets,2018

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urokinase-Type Plasminogen Activator Receptor (uPAR) in Inflammation and Disease: A Unique Inflammatory Pathway Activator;Biomedicines;2024-05-24

2. Navigating the future of retinitis pigmentosa treatments: A comprehensive analysis of therapeutic approaches in rd10 mice;Neurobiology of Disease;2024-04

3. HIF-1-Dependent Induction of β3 Adrenoceptor: Evidence from the Mouse Retina;Cells;2022-04-08

4. Development of inhibitors for uPAR: blocking the interaction of uPAR with its partners;Drug Discovery Today;2021-04

5. Biological insights in the pathogenesis of hypermobile Ehlers-Danlos syndrome from proteome profiling of patients' dermal myofibroblasts;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2021-04